Free Trial
Memorial Day Savings! Save $100 on MarketBeat All Access
Claim Your Discount
Claim MarketBeat All Access Sale Promotion
NASDAQ:CDXS

Codexis (CDXS) Stock Price, News & Analysis

Codexis logo
$2.49 -0.04 (-1.58%)
As of 04:00 PM Eastern

About Codexis Stock (NASDAQ:CDXS)

Advanced

Key Stats

Today's Range
$2.43
$2.58
50-Day Range
$1.47
$2.85
52-Week Range
$0.96
$3.87
Volume
865,188 shs
Average Volume
1.19 million shs
Market Capitalization
$226.34 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.00
Consensus Rating
Hold

Company Overview

Codexis Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
51st Percentile Overall Score

CDXS MarketRank™: 

Codexis scored higher than 51% of companies evaluated by MarketBeat, and ranked 502nd out of 866 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Codexis has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and 1 sell rating.

  • Upside Potential

    Codexis has a consensus price target of $5.00, representing about 100.8% upside from its current price of $2.49.

  • Amount of Analyst Coverage

    Codexis has only been the subject of 2 research reports in the past 90 days.

  • Read more about Codexis' stock forecast and price target.
  • Earnings Growth

    Earnings for Codexis are expected to grow in the coming year, from ($0.39) to ($0.22) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Codexis is -6.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Codexis is -6.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Codexis has a P/B Ratio of 5.19. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    5.33% of the float of Codexis has been sold short.
  • Short Interest Ratio / Days to Cover

    Codexis has a short interest ratio ("days to cover") of 3.66, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Codexis has recently decreased by 25.51%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Codexis does not currently pay a dividend.

  • Dividend Growth

    Codexis does not have a long track record of dividend growth.

  • News Coverage This Week

    MarketBeat has tracked 1 news article for Codexis this week, compared to 2 articles on an average week.
  • Search Interest

    12 people have searched for CDXS on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Codexis insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $6,624.00 in company stock.

  • Percentage Held by Insiders

    3.50% of the stock of Codexis is held by insiders.

  • Percentage Held by Institutions

    78.54% of the stock of Codexis is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Codexis' insider trading history.
Receive CDXS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Codexis and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CDXS Stock News Headlines

Read this warning immediately
Porter Stansberry, founder of one of the world's largest financial research firms, says he's breaking the biggest story of his 26-year career. A famous historian whose books have sold over 45 million copies in 65 languages is warning of a structural shift so large it has only one historical parallel - 1776. One Stanford economist calls it 'the biggest change ever - bigger than electricity, bigger than the steam engine.' Stansberry outlines the stocks to buy, the stocks to sell, and three money moves to position yourself on the right side of this shift.tc pixel
Codexis: Q1 Earnings Snapshot
Codexis Reports First Quarter 2026 Financial Results
See More Headlines

CDXS Stock Analysis - Frequently Asked Questions

Codexis' stock was trading at $1.63 at the beginning of 2026. Since then, CDXS shares have increased by 52.8% and is now trading at $2.49.

Codexis, Inc. (NASDAQ:CDXS) issued its quarterly earnings data on Thursday, May, 7th. The biotechnology company reported ($0.10) earnings per share for the quarter, topping analysts' consensus estimates of ($0.11) by $0.01. The biotechnology company earned $15.25 million during the quarter, compared to the consensus estimate of $14.53 million. Codexis had a negative net margin of 40.97% and a negative trailing twelve-month return on equity of 68.09%.
Read the conference call transcript
.

Codexis (CDXS) raised $0 in an initial public offering on Thursday, April 22nd 2010. The company issued 0 shares at a price of $0.00-$13.00 per share.

Codexis' top institutional shareholders include Private Advisor Group LLC (0.93%), Assenagon Asset Management S.A. (0.83%), Dimensional Fund Advisors LP (0.31%) and Lazard Asset Management LLC (0.31%). Insiders that own company stock include Opaleye Management Inc, Alison Moore, Byron L Dorgan, Stefan Lutz, Sriram Ryali, Kevin Norrett, Margaret Nell Fitzgerald and Georgia Erbez.
View institutional ownership trends
.

Shares of CDXS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Codexis investors own include Tesla (TSLA), NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), Netflix (NFLX), Walt Disney (DIS) and JPMorgan Chase & Co. (JPM).

Company Calendar

Last Earnings
5/07/2026
Today
5/22/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:CDXS
CIK
1200375
Employees
250
Year Founded
2002

Price Target and Rating

High Price Target
$5.00
Low Price Target
$5.00
Potential Upside/Downside
+100.8%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.37)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$43.97 million
Net Margins
-40.97%
Pretax Margin
-40.87%
Return on Equity
-68.09%
Return on Assets
-23.72%

Debt

Debt-to-Equity Ratio
0.94
Current Ratio
5.36
Quick Ratio
5.23

Sales & Book Value

Annual Sales
$70.39 million
Price / Sales
3.22
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.48 per share
Price / Book
5.19

Miscellaneous

Outstanding Shares
90,900,000
Free Float
87,716,000
Market Cap
$226.34 million
Optionable
Optionable
Beta
2.52

Social Links

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:CDXS) was last updated on 5/22/2026 by MarketBeat.com Staff.
From Our Partners